FOR HOSPITAL PHARMACY USE ONLY

Size: px
Start display at page:

Download "FOR HOSPITAL PHARMACY USE ONLY"

Transcription

1 V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM FOR HOSPITAL PHARMACY USE ONLY Use of Topical Wound Solutions with the V.A.C.ULTA Negative Pressure Wound Therapy System This information should be used in conjunction with the product labeling, including Instructions for Use, provided by the solution manufacturer and KCI for the V.A.C.ULTA Therapy System. This document provides information to assist hospital pharmacies in preparation and fulfillment of treating physician orders involving use of topical wound solutions using the V.A.C. VeraFlo Instillation Therapy available with the V.A.C.ULTA Therapy System. This information should be used in conjunction with (not as a replacement for) hospital policies and protocols related to preparation, labeling, and administration of pharmaceuticals in the hospital. Components of the V.A.C.Ulta Therapy System Solution Container Arm Solution Canister Arm Label For Irrigation Only Solution Bottle Instillation Cassette (V.A.C. VeraLink Cassette) Canister Filling Orders for V.A.C. VeraFlo Therapy Although physician orders will vary based on physician preference and facility protocols, there are certain prescription elements the pharmacy should consider when filling orders for topical solutions to be used with V.A.C. VeraFlo Therapy. Illustrations 1 and 2 provide examples of how a physician s order might appear, highlighting the essential elements that will allow the pharmacist to calculate the volume of instillation solution needed per day. Formula to calculate the Total Solution Required per Day of V.A.C. VeraFlo Therapy: [Number of Instillation Cycles per Day] X [Instillation Volume per Cycle] = Total Daily Instillation Volume

2 Illustration 1. Prescriber orders V.A.C. VeraFlo Therapy by identifying the V.A.C. Therapy time. Physician writes to pharmacist that s/he will instill 100mL of the prescribed solution at a soak time of 10 minutes and then will set the V.A.C. Therapy cycle time for 3 hours. 1. Use Table 1 to identify Number of Instillation Cycles per Day associated with prescribed Soak Time and V.A.C. Therapy Time. 2. Multiply the Number of Instillation Cycles per Day from the table by the Instillation Volume per Cycle. Answer: [8 Cycles per Day] X [100mL] = 800mL per Day Illustration 2. Prescriber orders V.A.C. VeraFlo Therapy, identifying the Number of Instillation Cycles per day Physician writes to pharmacist that s/he will instill 100mL of the prescribed solution 8 times per day at a soak time of 10 minutes per cycle. 1. Multiply the Number of Instillation Cycles per Day from the physician s order by the Instillation Volume per Cycle. Answer: [8 Cycles per Day] X [100mL] = 800mL per Day 2. To calculate the V.A.C. Therapy time for this physician order, use Table 1 by following the Soak Time column down to the prescribed Number of Instillation Cycles per Day, then follow row left to identify the associated V.A.C. Therapy time. Table 1. Answer: [8 Cycles per Day] and [10 min Soak Time] = 3 hours of V.A.C. Therapy Converts Approximate Number of Instillation Cycles by V.A.C. Therapy Time V.A.C. Therapy Time (hours) Approximate Number of Instillation Cycles per Day 10-minute Soak Time 15-minute Soak Time 20-minute Soak Time Table 2 illustrates the two techniques outlined above with additional order elements to consider for a complete V.A.C. VeraFlo Therapy physician order. Table 2. Potential V.A.C. VeraFlo Therapy Physician Order Order Item Illustration 1 Illustration 2 Solution Name Solution A Solution A Solution Concentration #.# % #.# % Instillation Volume per Cycle 100mL 100mL Soak Time 10 minutes 10 minutes V.A.C. Therapy Time 3 hours N/A Number of Instillation Cycles per Day N/A 8 cycles per day V.A.C. Therapy Negative Pressure Setting ###mmhg ###mmhg Wound Location Location X Location X

3 Most hospital pharmacies have established policies and protocols covering the mixing, labeling, and delivery of instillation/ irrigation solutions, including appropriate labeling and training. The following sections provide some information for pharmacies to consider as a part of their policies and protocols to the extent not already established. Differentiate the Solution Container Consider differentiating wound irrigation solution from systemic solutions (eg, intravenous fluids) by mixing and/or transferring physician-ordered irrigation into an irrigation bottle and using an irrigation screw cap adapter/spike adapter. Most pharmacies already stock an irrigation bottle, but some examples, with the appropriate irrigation cap adapter, include the B.Braun, Baxter irrigation and Thermo Scientific Nalgene irrigation bottles listed in Table 3. Table 3. Irrigation Bottles and Cap Adapters Note: The listing of certain products below is for illustrative purposes only and is not intended as an endorsement by KCI. There may be other suitable choices. Manufacturer Product Description Part Number B. Braun 0.9% Sodium Chloride 38mm Irrigation Bottle PIC Plastic Irrigation Containers 1,000mL (case of 16 bottles) Sterile Water 38 mm Irrigation Bottle PIC Plastic Irrigation Containers 1,000mL (case of 16 bottles) R R PIC Irrigation Container Spike Adaptor (case of 50 eaches) N2150 Baxter 0.9% Sodium Chloride 38 mm Irrigation Bottle 1,000mL (case of 12 bottles) 2F7124 Sterile Water 38mm Irrigation Bottle 1,000mL (case of 12 bottles) 2F7114 Hospira 1,000mL bottle with septum closure from Thermo Scientific Nalgene mm Screw Cap Adapter.* For use with Aqualite semi-rigid pour bottle system and other 38mm bottles (case of 20 eaches) *Cap adapter can be used for any 38mm irrigation bottle from any supplier Twistit White Rubber Stopper, size 6 from Cole Palmer EW

4 Label the Container Most hospital pharmacies have protocols in place for use of labels to distinguish irrigation solutions from systemic solutions. Consider covering the irrigation bottle with conspicuously colored labels with a note, such as the example in Figure 1. Figure 1. Auxiliary Label For Irrigation Only FOR IRRIGATION ONLY Your hospital may already have appropriate labels in pharmacy. The label pictured above may be ordered in quantities of 1,000 at the website Require Trained Clinicians to Check Out A final recommendation would be to require only V.A.C. VeraFlo Therapy-trained clinicians to sign for the topical wound solution, either at the pharmacy or with the pharmacy runner. Upon request, the KCI sales representative can provide a list of the trained clinicians at your facility.

5 Examples of V.A.C. VeraFlo Therapy Physician Order Templates Following are several examples of physician orders showing the time for V.A.C. Therapy and the Number of Instillation Cycles per Day. These are provided as examples only. Example 1: V.A.C. VeraFlo Therapy Physician Order (with V.A.C. Therapy time indicated) Solution Name Solution Concentration Instillation Volume per Cycle Soak Time V.A.C. Therapy Time V.A.C. Therapy Negative Pressure Setting Wound Location Example 2: V.A.C. VeraFlo Therapy Physician Order (with Number of Instillation Cycles per Day indicated) Solution Name Solution Concentration Instillation Volume per Cycle Soak Time Number of Instillation Cycles per Day V.A.C. Therapy Negative Pressure Setting Wound Location Note: Specific indications, contraindications, warnings, precautions, and safety information exist for KCI products and therapies. Please consult a physician and product instructions for use prior to application. Rx only KCI Licensing, Inc. All rights reserved. Aqualite is a trademark of Hospira, Inc. PIC is a trademark of B.Braun. Twistit is a trademark of Cole-Parmer. All other trademarks designated herein are proprietary to KCI Licensing, Inc., its affiliates and/or licensors. DSL# US (Rev.11/14)

V.A.C. VeraFlo Therapy can help.

V.A.C. VeraFlo Therapy can help. WOUND CARE IS COMPLEX & COSTLY Therapy can help. PROBLEM Complex wounds pose challenges to clinicians and patients in terms of achieving desired outcomes while managing healthcare costs. 1-5 OUTCOMES &

More information

For optimal incision management. The PREVENA Therapy portfolio of closed incision management solutions.

For optimal incision management. The PREVENA Therapy portfolio of closed incision management solutions. For optimal incision management. The PREVENA Therapy portfolio of closed incision management solutions. The PREVENA Incision Management System manages the surgical incision by: Helping to hold incision

More information

V.A.C. Therapy Patient Guide. Are you suffering from a wound? Ask your doctor about V.A.C. Therapy and whether it may be right for you.

V.A.C. Therapy Patient Guide. Are you suffering from a wound? Ask your doctor about V.A.C. Therapy and whether it may be right for you. V.A.C. Therapy Patient Guide Are you suffering from a wound? Ask your doctor about V.A.C. Therapy and whether it may be right for you. kci1.com 800.275.4524 Table of Contents Wound Healing is a Process...2

More information

V.A.C. Therapy Safety Information

V.A.C. Therapy Safety Information Bringing Safety Home V.A.C. Therapy Safety Information Bleeding Precautions Dressing Change Frequency Foam Removal Important Information 2 Prior to use of V.A.C. Therapy System it is important for the

More information

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations 49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a

More information

V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM)

V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM) V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM) SAFETY INFORMATION AND V.A.C. VERAFLO CLEANSE CHOICE DRESSING SYSTEM APPLICATION INSTRUCTIONS ONLY FOR USE WITH THE KCI V.A.C.ULTA

More information

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation 6/22/2014; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Estradiol 1% Stock Powder Blend 2.000 g Estriol (Micronized), USP 0.080 g Medisca CapsuBlend -H TBD Sodium Chloride,

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

WHEN THERE S A NEED FOR EPIDERMIS

WHEN THERE S A NEED FOR EPIDERMIS WHEN THERE S A NEED FOR EPIDERMIS PRESS START The automated CELLUTOME Epidermal Harvesting System The CELLUTOME System is an innovative epidermal harvesting device which can be easily integrated into your

More information

JuggerLoc Bone-to-Bone System for Ankle Syndesmosis Fixation. Surgical Technique

JuggerLoc Bone-to-Bone System for Ankle Syndesmosis Fixation. Surgical Technique JuggerLoc Bone-to-Bone System for Ankle Syndesmosis Fixation Surgical Technique Table of Contents Position and Preparation... 2 Incision... 2 Fracture Reduction... 2 Drill Fibula and Tibia... 3 JuggerLoc

More information

V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM)

V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM) V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM) SAFETY INFORMATION ONLY FOR USE WITH THE KCI V.A.C.ULTA THERAPY SYSTEM Rx Only TABLE OF CONTTS Important Information for Users...

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM)

V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM) V.A.C.ULTA NEGATIVE PRESSURE WOUND THERAPY SYSTEM (V.A.C.ULTA THERAPY SYSTEM) SAFETY INFORMATION ONLY FOR USE WITH THE KCI V.A.C.ULTA THERAPY SYSTEM Rx Only TABLE OF CONTENTS Important Information for

More information

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS

ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS ENCEFAL-VAC SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENCEFAL-VAC Live lyophilised vaccine for chickens 2. QUALITATIVE AND QUANTITATIVE

More information

NCCN Chemotherapy Order Templates

NCCN Chemotherapy Order Templates USER GUIDE NCCN Chemotherapy Order Templates (NCCN Templates ) Access to the NCCN Chemotherapy Order Templates (NCCN Templates ) for non-commercial users is available via subscription. Prior to accessing

More information

Technique Manual Technique Manual Rev. A 01/11/2011

Technique Manual Technique Manual Rev. A 01/11/2011 Technique Manual Technique Manual Table of Contents Introduction 4 Indications 5 Instrumentation 6 Frame Assembly 7 Position Guide 8-9 Tips and Tricks 10-13 Cleaning 14 Sterilization 14 Storage Instructions

More information

MuGard Oral Mucoadhesive provides effective management of oral mucositis

MuGard Oral Mucoadhesive provides effective management of oral mucositis INFORMATION FOR PATIENTS MuGard Oral Mucoadhesive provides effective management of oral mucositis How does MuGard work? When you use MuGard, it helps you manage your symptoms of oral mucositis. MuGard

More information

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY Version 4.0 March 2016 Review date March 2018 Introduction It is the purpose of this policy to provide clear guidelines that

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

CoAxial Spray Kit. Simplifying the Application of Platelet-Rich Plasma onto Graft Material. Surgical Technique

CoAxial Spray Kit. Simplifying the Application of Platelet-Rich Plasma onto Graft Material. Surgical Technique CoAxial Spray Kit Simplifying the Application of Platelet-Rich Plasma onto Graft Material Surgical Technique 1 CoAxial Spray Kit Surgical Technique CoAxial Spray Kit The Zimmer Biomet Biologics CoAxial

More information

V.A.C.Ulta Negative Pressure Wound Therapy System. Monograph

V.A.C.Ulta Negative Pressure Wound Therapy System. Monograph V.A.C.Ulta Negative Pressure Wound Therapy System Monograph Table of Contents Preface... 3 Introduction... 3 Wound Management with NPWT and NPWTi... 5 Literature Review of NPWT... 6 Literature Review of

More information

Artesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6

Artesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6 LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer Carton 1. NAME OF THE MEDICINAL PRODUCT Artesun 120mg * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 120 mg artesunate powder

More information

INnate. Surgical Technique Guide. Anatomic Fixation in Your Hands. The INnate Implant

INnate. Surgical Technique Guide. Anatomic Fixation in Your Hands.   The INnate Implant INnate Surgical Technique Guide The INnate Implant Anatomic Fixation in Your Hands www.exsomed.com INDICATIONS FOR USE The ExsoMed INnate Cannulated Screw System is intended for fixation of intra-articular

More information

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) PATIENT / USER INFORMATION LEAFLET Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) Read all of this leaflet carefully before you start taking this medicine. Keep this

More information

HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE

HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE 1 HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. The color of your HumaPen

More information

JuggerKnot Soft Anchor 1.0 mm Mini

JuggerKnot Soft Anchor 1.0 mm Mini JuggerKnot Soft Anchor 1.0 mm Mini Ulnar Collateral Ligament (UCL) Repair of the Thumb Surgical Technique Surgical Protocols by Mark Rekant, M.D. A. Lee Osterman, M.D. One Surgeon. One Patient. Over 1

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 0.25 mg/ml, eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains 0.345 mg ketotifen fumarate corresponding

More information

Quality, Safety and Sourcing in Unlicensed Medicines

Quality, Safety and Sourcing in Unlicensed Medicines Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?

More information

Guidance on Bulk Prescribing for Care Home Patients

Guidance on Bulk Prescribing for Care Home Patients Guidance on Bulk Prescribing for Care Home Patients Introduction Many patients in care homes taking medicines when required (PRN) can inevitably present problems for the prescriber in determining the quantity

More information

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml 12/20/2018; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier, USP 10 MU Sucrose, NF 23.00 g Propylene Glycol, USP 7.0 ml Medisca Oral Mix (Flavored Suspending Vehicle) 50.0 ml Medisca

More information

Ingredient Listing Qty. Unit NDC # Supplier ml

Ingredient Listing Qty. Unit NDC # Supplier ml 8/28/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Progesterone 0.25%/Spironolactone 0.5% Stock Solution 5.00 ml Medisca Foamil Base 45.00 g Alcohol (95%), USP q.s. to

More information

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through

More information

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 11/16/17 SECTION: DRUGS LAST REVIEW DATE: 11/16/17 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 11/16/17 SECTION: DRUGS LAST REVIEW DATE: 11/16/17 LAST CRITERIA REVISION DATE: ARCHIVE DATE: LEVALBUTEROL HFA (levalbuterol tartrate) inhalation aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SODIUM CHLORIDE- sodium chloride injection, solution B. Braun Medical Inc. ---------- 0.9% Sodium Chloride Injection USP Partial Fill DESCRIPTION Each ml of 0.9% Sodium Chloride Injection USP contains:

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

PARENTERAL PREPARATIONS

PARENTERAL PREPARATIONS PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk, para enteron, beside the intestine) dosage forms differ from all other drug dosage forms, because they are injected directly into body tissue through

More information

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation Note: Glucosamine Sulfate Potassium Chloride 1267 mg is equivalent to Glucosamine 750 mg. 11/8/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Chondroitin Sulfate Sodium,

More information

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier 9/17/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Aloe Vera (Powder) (Freeze Dried) 0.200 g Tacrolimus 5% Stock Powder Blend 0.600 g Ethoxy Diglycol 1.0 ml Medisca U-Mild

More information

St. Jude Medical 8-Channel Adapter. Clinician's Manual

St. Jude Medical 8-Channel Adapter. Clinician's Manual St. Jude Medical 8-Channel Adapter Clinician's Manual CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. For U.S. California Only: Proposition 65, a State of California

More information

The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1

The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1 The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1 An important immunotherapy option for patients with grass allergies Effective during the first

More information

Artesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING

Artesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING LABELLING 1 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton (pack of 1 vial and 2 ampoules) 1. NAME OF THE MEDICINAL PRODUCT Artesun * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 60 mg artesunate

More information

Guideline on the Regulation of Therapeutic Products in New Zealand

Guideline on the Regulation of Therapeutic Products in New Zealand Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This

More information

Cofact can be used for: The treatment of haemorrhages or the prevention of peri-operative haemorrhages as the result of

Cofact can be used for: The treatment of haemorrhages or the prevention of peri-operative haemorrhages as the result of Package leaflet: Information for the user Cofact 250 IU, human prothrombin complex, 250 IU factor IX per vial, powder and solvent for solution for injection. Cofact 500 IU, human prothrombin complex, 500

More information

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation 2/8/2014; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Baclofen, USP 1.000 g Cyclobenzaprine Hydrochloride, USP 1.000 g Diclofenac Sodium, USP 1.500 g Lidocaine Hydrochloride,

More information

Ingredient Listing Qty. Unit NDC # Supplier TBD. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier TBD. Sterile Preparation 8/16/2018; Page 1 SUGGESTED FORMULATION Acyclovir, USP Ingredient Listing Qty. Unit NDC # Supplier Mineral Oil (Light), NF 3.0 ml Polyox TM WSR-301 Oral Adhesive Paste* *Formula # F 006 397 available on

More information

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February

More information

Graft Delivery Devices

Graft Delivery Devices Graft Delivery Devices About Graft Delivery Devices Nordson MEDICAL Nordson MEDICAL is your partner in the global life sciences market providing innovative components, devices and custom OEM solutions

More information

New regulatory requirements DPCS Regulations 2017

New regulatory requirements DPCS Regulations 2017 New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...

More information

Do not re use needles. If you do you might not get your dose (underdosing) or get too much (overdosing) as the needle could block.

Do not re use needles. If you do you might not get your dose (underdosing) or get too much (overdosing) as the needle could block. What are the ingredients in TOUJEO? Active ingredient: insulin glargine Inactive ingredients: zinc, m cresol, glycerol and water for injection Hydrochloric acid and sodium hydroxide may be added to adjust

More information

Switching to Enterprise Drugs

Switching to Enterprise Drugs ................................................................................................... Switching to Enterprise Drugs Pharmacy Technology Solutions May, 2013 Filling New Prescriptions: Switching

More information

Thailand s experience in developing the Reclassification guideline

Thailand s experience in developing the Reclassification guideline Ms.Charunee Krisanaphan Pharmacist, Senior Professional level Standards and Regulations Division, Bureau of Control Thai Food and October 22, 2014 Outlines Definition Existed guideline Process of developing

More information

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems CATHETER ACCESS KIT Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Table of Contents Contents... 3 Description... 3 Indications... 3 Contraindications... 3

More information

DVR Crosslock Distal Radius Plating System. Product Brochure

DVR Crosslock Distal Radius Plating System. Product Brochure DVR Crosslock Distal Radius Plating System Product Brochure One Surgeon. One Patient. Over 1 million times per year, Biomet helps one surgeon provide personalized care to one patient. The science and art

More information

Lidocaine Hydrochloride 2%, Metronidazole 2%, Misoprostol % Topical Ointment (Suspension, 30 g) Ingredient Listing Qty. Unit NDC # Supplier

Lidocaine Hydrochloride 2%, Metronidazole 2%, Misoprostol % Topical Ointment (Suspension, 30 g) Ingredient Listing Qty. Unit NDC # Supplier 6/18/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Lidocaine Hydrochloride, USP Metronidazole, USP 0.600 g Misoprostol 1% Dispersion, USP 0.072 g Ethoxy Diglycol 3.0 ml

More information

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

POLICY AND PROCEDURE DOCUMENT NAME: Drug Recall Notification Process

POLICY AND PROCEDURE DOCUMENT NAME: Drug Recall Notification Process PAGE: 1 of 6 SCOPE: Centene Corporate, Magnolia Health Plan Department, and Envolve Solutions. PURPOSE: To identify and notify prescribers and members affected by FDA-required or voluntary drug withdrawals

More information

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)

Pharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK) ESPEN Congress Leipzig 2013 Pharmaceutical Session Pharmaceutical risk management strategies for parenteral nutrition J. Eastwood (UK) Pharmaceutical risk management strategies for parenteral nutrition

More information

Pharmacy Policy Bulletin

Pharmacy Policy Bulletin Pharmacy Policy Bulletin Title: Policy #: New Jersey Formulary Exception Policy Rx.01.193 Application of pharmacy policy is determined by benefits and contracts. Benefits may vary based on product line,

More information

DISCOVER NEW HORIZONS IN FLUID DRAINAGE. Bringing Safety and Convenience to Fluid Drainage Management

DISCOVER NEW HORIZONS IN FLUID DRAINAGE. Bringing Safety and Convenience to Fluid Drainage Management DISCOVER NEW HORIZONS IN FLUID DRAINAGE Bringing Safety and Convenience to Fluid Drainage Management DRAIN ASEPT Pleural and Peritoneal Drainage Catheter System 600mL or 1,000mL Evacuated Drainage Bottle

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION ALPROLIX [pronounced all prō liks] Coagulation Factor IX (Recombinant), Fc Fusion Protein This leaflet is part III of a three-part "Product Monograph" published when ALPROLIX

More information

SureLock All-Suture Anchor System

SureLock All-Suture Anchor System SureLock All-Suture Anchor System Guide for Bankart Repair Surgical Technique 2 SureLock All-Suture System Bankart Repair Surgical Technique Figure 1 *Curved and straight drill guides are available for

More information

StageOne. Shoulder Cement Spacer Molds. Surgical Technique

StageOne. Shoulder Cement Spacer Molds. Surgical Technique StageOne Shoulder Cement Spacer Molds Surgical Technique One Surgeon. One Patient. Over 1 million times per year, Biomet helps one surgeon provide personalized care to one patient. The science and art

More information

Packaging Taking a sample for testing Testing the sample Opening the bottle Using the drug for a peaceful death

Packaging Taking a sample for testing Testing the sample Opening the bottle Using the drug for a peaceful death 232 The Peaceful Pill Handbook Veterinary Nembutal Packaging Taking a sample for testing Testing the sample Opening the bottle Using the drug for a peaceful death Packaging The preferred form of veterinary

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Respiporc FLU3 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml contains:

More information

ADT Booster Data Sheet

ADT Booster Data Sheet 1. PRODUCT NAME ADT Booster. Diphtheria and Tetanus Vaccine (adsorbed) for revaccination. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ADT Booster is a suspension for intramuscular injection, containing

More information

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999

Student Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 Questions 1-25 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions

More information

In Brief SUBJECT ADMINISTRATIVE PROCEDURES FOR THE IMPORTATION OF NON-BEVERAGE ETHYL ALCOHOL

In Brief SUBJECT ADMINISTRATIVE PROCEDURES FOR THE IMPORTATION OF NON-BEVERAGE ETHYL ALCOHOL MEMORANDUM D10-14-19 In Brief Ottawa, April 19, 2002 SUBJECT ADMINISTRATIVE PROCEDURES FOR THE IMPORTATION OF NON-BEVERAGE ETHYL ALCOHOL This Memorandum outlines the administrative procedures to be followed

More information

Bactisure Wound Lavage. Advancing Biofilm Removal

Bactisure Wound Lavage. Advancing Biofilm Removal Wound Lavage Advancing Biofilm Removal Wound Lavage Wound Lavage is used to remove debris, including microorganisms, from wounds using pulsed (jet) lavage. The clear, colorless, low-odor solution is a

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor

More information

Intravenous Fluid and Drug Therapy

Intravenous Fluid and Drug Therapy 11 Intravenous Fluid and Drug Therapy OUTLINE Overview Direct Intravenous Injections Continuous Intravenous Injections Solution Additives Calculating IV Components as Percentages Calculating IV Flow Rates

More information

PRESCRIBING INFORMATION ADRENALIN TOPICAL SOLUTION. Epinephrine Chloride Topical Solution, manufacturer standard 30 mg / 30 ml (1 mg/ml)

PRESCRIBING INFORMATION ADRENALIN TOPICAL SOLUTION. Epinephrine Chloride Topical Solution, manufacturer standard 30 mg / 30 ml (1 mg/ml) PRESCRIBING INFORMATION ADRENALIN TOPICAL SOLUTION Epinephrine Chloride Topical Solution, manufacturer standard 30 mg / 30 ml (1 mg/ml) HEMOSTATIC AGENT For Topical Application Only DO NOT INJECT DATE

More information

MatrixNEURO. The next generation cranial plating system.

MatrixNEURO. The next generation cranial plating system. MatrixNEURO. The next generation cranial plating system. Technique Guide CMF Matrix This publication is not intended for distribution in the USA. Instruments and implants approved by the AO Foundation

More information

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES CONTENTS

More information

Before you use NovoThirteen. When NovoThirteen should not be used

Before you use NovoThirteen. When NovoThirteen should not be used NovoThirteen 2500 U catridecacog (rys) Recombinant coagulation factor X Consumer Medicine nformation What is in this leaflet What NovoThirteen is used for 1 Before you use NovoThirteen 1 Using NovoThirteen...

More information

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges.

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. MS9662 MS9663 HumaPen LUXURA INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. Your HumaPen LUXURA

More information

Elcometer 138/2. Surface Contamination Kit. Operating Instructions

Elcometer 138/2. Surface Contamination Kit. Operating Instructions Elcometer 138/2 English Surface Contamination Kit Operating Instructions R English is a registered trademark of Elcometer Limited. All other trademarks acknowledged. Copyright Elcometer Limited. 2010.

More information

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Package leaflet: Information for the user Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Read all of this leaflet carefully before you start using

More information

Homely Remedies Guidance for Care Homes

Homely Remedies Guidance for Care Homes Homely Remedies Guidance for Care Homes What is a homely remedy? Homely or household remedy is another name for a non-prescription medicine which is used in a care home for the short term management of

More information

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges.

For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. MS9673 HumaPen LUXURA HD INSULIN DELIVERY DEVICE INSTRUCTIONS FOR USE For use only with Lilly 3 ml insulin cartridges (100 units/ml). Do not use other brands of insulin cartridges. The colour of your HumaPen

More information

40 Use and Supply of Drugs or Medicines in Optometric Practice

40 Use and Supply of Drugs or Medicines in Optometric Practice 40 Use and Supply of Drugs or Medicines in Optometric Practice Guideline 40.01 The optometrist has a duty to take due care in the use of drugs in optometric practice and to only supply drugs when it is

More information

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Harmonization effort for OTC monograph in Taiwan Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Outline Background OTC drug registration OTC monographs Future directions

More information

Jones & Bartlett Learning, LLC. NOT FOR SALE OR DISTRIBUTION

Jones & Bartlett Learning, LLC. NOT FOR SALE OR DISTRIBUTION Forfunlife/Shutterstock Chapter 7 Dosage Calculations CHAPTER OUTLINE 7- Comparing the Supply to the Ordered Dose 7-2 Methods of Dosage Calculation A. Ratio-Proportion. Fractional Ratio-Proportion 2. Linear

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

The AperFix II System

The AperFix II System The AperFix II System A Complete Anatomic Solution Transtibial Surgical Technique 2 AperFix II System Transtibial Surgical Technique Figure 1 A Complete Anatomic Solution The Cayenne Medical AperFix and

More information

ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL.

ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL. ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL. How active hands-on involvement in managing the incision healing process helps to protect your

More information

Implant And Abutment Level Impressions

Implant And Abutment Level Impressions Implant And Abutment Level Impressions Implant And Abutment Level Impressions Pick-Up Impression Copings Certain Internal Connection is illustrated below. 1. Select the proper Pick-Up Impression Coping

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis Pesti emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml

More information

Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv

Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv Institute for State Control of Veterinary Biologicals and Medicines Ústav pro státní kontrolu veterinárních biopreparátů a léčiv DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY

More information

JuggerKnot Soft Anchor 1.0 mm Mini

JuggerKnot Soft Anchor 1.0 mm Mini JuggerKnot Soft Anchor 1.0 mm Mini Ulnar Collateral Ligament (UCL) Repair of the Thumb Surgical Technique Surgical Protocols by Mark Rekant, M.D. A. Lee Osterman, M.D. One Surgeon. One Patient. Over 1

More information

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY

CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY COMMUNITY PHARMACY OPERATIONS Technician Duties Related to Dispensing Over-the-Counter Drugs and

More information

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and

More information

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon Package leaflet: Information for the user GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon Read all of this leaflet carefully before you are given this injection because it

More information

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension 3 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Isopto Carpine safely and effectively. See full prescribing information for Isopto Carpine. Isopto

More information

Practical 3 Extemporaneous Preparations Solutions. Name: Group: Date:

Practical 3 Extemporaneous Preparations Solutions. Name: Group: Date: Practical 3 Extemporaneous Preparations Solutions Name: Group: Date: FILTRATION Unwanted particulate matter may be removed from solutions by the process of filtration. Filtration may be either fine or

More information

Guidance for Pharmacists on Extemporaneous Dispensing

Guidance for Pharmacists on Extemporaneous Dispensing Guidance for Pharmacists on Extemporaneous Dispensing Pharmaceutical Society of Ireland Version 1 June 2015 Contents 1. Introduction 2 2. Legislative Basis and Implications 3 3. Guidance 4 3.1 Key Responsibilities

More information

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for MYALEPT (metreleptin) for injection Instructions for Use MYALEPT (MAI-uh-lept) (metreleptin) for injection Vial A healthcare provider should show you how to inject MYALEPT before you use it for 8 Do not

More information

N-Force Fixation System. Surgical Technique

N-Force Fixation System. Surgical Technique N-Force Fixation System Surgical Technique Table of Contents Features... 2 Indications/Contraindications... 3 Surgical Technique 4.0 mm...6 11 Step 1: Preoperative Radiographic Fracture Assessment and

More information

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) PACKAGE LEAFLET: INFORMATION FOR THE USER Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) Read all of this leaflet carefully before you start using this medicine

More information